Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China · Delayed Price · Currency is CNY 20.68
-0.05 (-0.24%)
Feb 13, 2026, 3:00 PM CST
SHA:603896 Market Cap
SHA:603896 has a market cap or net worth of 4.1 billion as of February 13, 2026. Its market cap has increased by 3.35% in one year.
Market Cap
4.10B
Enterprise Value
3.59B
Revenue
642.66M
Ranking
n/a
PE Ratio
29.88
Stock Price
20.68
Market Cap Chart
Since May 10, 2017, SHA:603896's market cap has increased from 2.32B to 4.10B, an increase of 76.45%. That is a compound annual growth rate of 6.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.10B | 6.71% |
| Dec 31, 2025 | 3.84B | -8.63% |
| Dec 31, 2024 | 4.20B | -34.21% |
| Dec 29, 2023 | 6.39B | -18.28% |
| Dec 30, 2022 | 7.82B | -11.47% |
| Dec 31, 2021 | 8.83B | 75.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.51B |
| Hinova Pharmaceuticals | 4.50B |
| Guanhao Biotech | 4.14B |
| Boji Medical Technology | 4.07B |
| Zhejiang Wecome Pharmaceutical Company | 4.03B |
| Baolingbao Biology | 4.00B |
| Shenzhen Bioeasy Biotechnology | 3.97B |
| Qingdao Vland Biotech INC. | 3.95B |